UK MHRA: Bacteriophage Developers Wanted ‘More Clarity’ On UK Framework

 
• By Eliza Slawther

Julian Beach, interim executive director of healthcare quality and access at the UK drug regulator, the MHRA, tells the Pink Sheet how the agency is responding to increased efforts to develop bacteriophage therapies.

Bacteriophages attacking a bacterial cell
The MHRA released its bacteriophage guidance on 4 June (Shutterstock)

More from Interviews

More from R&D